How to Select a CER (Clinical Evaluation Report) Writer

How to Select a CER (Clinical Evaluation Report) Writer

This was a valuable contribution in the Medical Devices Group from member Julie Omohundro, Principal Consultant at Class Three, LLC that was too good not to share more broadly. These are her words.

These are the qualifications I would look for in a CER writer. I would be happy to hear what criteria others have found helpful.

1. Writing experience. Significant experience writing scientific, medical/clinical, and technical content. Experience writing CERs that conform to MEDDEV 2.7.1 would be a plus.

-- Many medical writers will have experience that limited to clinical trial documents such as protocols, consent documents, and clinical study reports; this experience is not particularly relevant to CERs. Some may have experience with summaries of safety and effectiveness, investigator’s brochures, and/or report of prior investigations, which are much more on target. Experience with review articles for a scientific or medical journal would also be on target. 

-- Device RA professionals will have experience with technical content; many will have little or no experience with scientific or medical content.

2. Clinical knowledge. Someone who is knowledgeable in the therapeutic area. Knowledge directly applicable to the specific device’s intended use would be a plus.

-- Medical writers are likely to be strong on clinical knowledge. The only questions to be asked is in which therapeutic areas.

-- Device RA professionals who have managed 510(k)s or De novo petitions that were supported by clinical trials will usually have some level of clinical knowledge. If they have prepared regulatory applications for devices in the same therapeutic area, their clinical knowledge will be more applicable to the CER(s) you need written. Those who have led PMAs are likely to have deep but narrow clinical knowledge, defined by the intended use of their PMA devices.

3. Device knowledge. Someone with knowledge of devices used in the therapeutic area and often in the technology (eg, diagnostics, software, imaging). Knowledge of the specific device type would be a plus.

-- Most medical writers have no device knowledge. Some have knowledge limited to specific devices that were the subject of clinical trials for which the writer developed study documents. Those with broader device experience are relatively few and far between, and most of the experience will be with cardiology devices.

-- There should be any number of device RA professionals who have experience with devices used in the relevant therapeutic area. If the device type is fairly common (e.g., a stent), there will also be a good number who have with the specific device type, which is an obvious plus. If the device is less common or novel, then you can comfortably settle for experience with devices in the same therapeutic area.

4. Regulatory knowledge. Someone with a solid knowledge of MEDDEV 2.7.1 is a must. Knowledge of the knowledge of the current version, an understanding of the EU regulatory framework for devices, especially the role of the notified bodies in review of a CER, would be pluses.

-- Medical writers could have through knowledge of MEDDEV 2.7.1, but most are pharma writers and may never have heard of it. Some know a good bit about the EU regulatory framework for medical devices, but most know little to nothing about it.

-- Device RA professionals who work with CE marked devices will a solid understanding of the EU regulation of medical devices, but many will not have a solid knowledge of MEDDEV 2.7.1. I think the main strength here is their potential understanding of the review of CERs by notified bodies, the difference between review at certification and renewal versus periodic annual review, and how everything that is going on in the EU is likely to impact that review, and what that may mean for your CER.

In applying these qualifications, it is important to weigh the specific needs of your CER. A Class III CER rests heavily on clinical trial data, and therefore needs a writer with a good understanding of clinical trials, most likely a medical writer or a device RA professional with PMA experience. Class I and Class II CERs rest heavily on data in the literature and post-market surveillance data, so clinical trial knowledge is less critical. I also think there is a difference in what is needed to write a new CER from scratch, update an existing CER to add new data, or to update an existing CER from Rev 3 to Rev 4.

You also need to consider what you will bring to the effort. If you have an MD or other clinician who is going to be actively involved in the preparation of the CER, then the clinical knowledge of the writer becomes much less critical. Similarly, if someone knowledgeable about the device technology is going to be actively involved, then writer’s technical knowledge becomes less critical. If you are going to provide the writer with the results of the literature search(es), then the writer doesn’t need to know their way around PubMed; otherwise, they do.

The biggest mistake I’ve seen is to insist on a writer that has all of the pluses, which may be driven more by recruiters competing for a placement than by the device companies themselves. 

For most CERs, a writer with broad content experience, a knowledge of the therapeutic area, a familiarity with devices with the same general type of technology, and knowledge of MEDDEV 2.7.1 will be quite up to the task, and not necessarily easy to find. If you insist on someone who has experience specifically writing CERs to MEDDEV 2.7.1 Rev 4, for the same specific type of device, for the same intended use, you may be pointlessly searching for a needle in a haystack, and also end up paying a higher rate for this unique combination, when it really wasn’t necessary.

+++

About the author: Joe Hage leads the world’s largest Medical Devices Group(350,000+ members), the industry’s only spam-free, curated forum for intelligent conversations with medical device thought leaders. Mr. Hage’s medical device marketing services help companies engage qualified prospects and his family of 10x Medical Device Conferences unites Medical Devices Group members in fun and educational forums each year.

?




Yes, well written. But I think one characteristic is missing. The CER person should also have the ability to bring it (the clinical and the technical involved persons) all together. In my experience some clinicians are pretty hard to manage, e.g. if a specified time to target shall be followed. While on the other side some developers won't really talk (make the writer understand ) to a non-tech person. Just a thought...

回复
J o e H a g e

Kinda retired but helping medical device friends at medgroup.biz/premium

7 年

Here's a conversation about the topic from the Medical Devices Group: How and Where to Find CER Writers at https://www.dhirubhai.net/groups/78665/78665-6295055149215858689

Adam Steadman

Senior Global Leader in Medical Device & Diagnostics | Investor | Advisor

7 年

Agree, Joe, very well written. Nice article Julie Omohundro.

回复

要查看或添加评论,请登录

J o e H a g e的更多文章

  • What is the Role of Sales Now? feat. @TedRubin

    What is the Role of Sales Now? feat. @TedRubin

    My client has thousands of leads from whitepapers and webinars and Sales can’t convert them. It came up in conversation…

    7 条评论
  • My Most Important Advice for 2019

    My Most Important Advice for 2019

    I wrote "A content shock to the system" as my "most important update" for 2018. This beautifully animated Lucia video…

    3 条评论
  • How to win new appointments with virtual LinkedIn strangers

    How to win new appointments with virtual LinkedIn strangers

    When two strangers set appointments with my client, I documented this repeatable method to win new business. There are…

    3 条评论
  • I am ugly. And so are you.

    I am ugly. And so are you.

    It needs to be said. I am an ugly man.

    19 条评论
  • Can medical device companies overcome content shock?

    Can medical device companies overcome content shock?

    Medical device marketers, have you heard of “Content Shock?” Mark Schaefer coined the term four years ago, defining it…

    5 条评论
  • How to improve your medical device supply chain?

    How to improve your medical device supply chain?

    I was talking with Carlos Soares, the newest member of our Medical Devices Group Advisory Board, about supply chain…

  • This is no way to raise money, people

    This is no way to raise money, people

    I can't believe how often I get a message like this one. I'll translate it into my native Brooklyn, New York-ese.

    10 条评论
  • MDUFA: Medical Device User Fees go up in 2018

    MDUFA: Medical Device User Fees go up in 2018

    I had the opportunity to speak with Terry Sweeney of Philips Healthcare about the upcoming changes in the Medical…

    8 条评论
  • You're Going to be Disappointed

    You're Going to be Disappointed

    I got an email today from a reader, Dear Medical Marcom, I am working for a newly established medical supply company as…

    4 条评论
  • The Six YES Answers You Need Before You Start Your Lead Generation Program

    The Six YES Answers You Need Before You Start Your Lead Generation Program

    A reader wrote me, "I was reading your website very carefully and a lot of the recommended actions we are working on. I…

    3 条评论

社区洞察

其他会员也浏览了